Israel on the pharma frontier: How AION Labs is incubating the next drug development breakthrough
Jan 22, 2025•53 min•Season 2Ep. 43
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
This week, The Jerusalem Post’s Yuval Levy and Abigail Rubinstein interview AION Labs CTO Dr. Yair Benita.
Yuval, Abigail, and Yair will talk about recent advancements in the AI pharmaceutical industry, as well as the work AION Labs is doing to propel technological innovation in the field of drug development.
Yair will discuss his venture studio’s collaboration with major corporations such as Pfizer, Merck, Teva, AstraZeneca, and Amazon to support independent Israeli startups as they pursue solutions to some of the biggest challenges in the medical field.
He will also dive into the details of AI in the scientific world and what the future holds for the world of medicine.
Yuval, Abigail, and Yair will talk about recent advancements in the AI pharmaceutical industry, as well as the work AION Labs is doing to propel technological innovation in the field of drug development.
Yair will discuss his venture studio’s collaboration with major corporations such as Pfizer, Merck, Teva, AstraZeneca, and Amazon to support independent Israeli startups as they pursue solutions to some of the biggest challenges in the medical field.
He will also dive into the details of AI in the scientific world and what the future holds for the world of medicine.
For the best experience, listen in Metacast app for iOS or Android